SYQUANT CAPITAL SAS
Q3 2025 13F-HR Holdings
Net value change ($000)
+46,842
(15.5%)
New positions
13
Sold out positions
10
Turnover %
123.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VRNA | 128,939 | NEW |
| 89bio, Inc. | 38,127 | NEW |
| KEL | 33,176 | 36.5% |
| IPG | 23,843 | NEW |
| INFA | 13,358 | NEW |
| CEPF | 5,095 | NEW |
| WNS | 3,711 | NEW |
| CRH | 2,856 | NEW |
| MBVI | 2,024 | NEW |
| AEXA | 1,366 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| BPMC | -103,262 | -100.0% |
| Enstar Group LTD | -24,153 | -100.0% |
| WBA | -14,743 | -100.0% |
| TRIUMPH GROUP INC | -14,631 | -100.0% |
| JNP | -12,084 | -100.0% |
| SpringWorks Therapeutics, Inc. | -11,607 | -100.0% |
| SKAA | -11,606 | -100.0% |
| DNB | -11,352 | -100.0% |
| APP | -2,514 | -100.0% |
| CON | -1,395 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|